)

Joey would have been 20 in March. But he is forever 10. 

 

   Joey was a very energetic 5th grader. He was a math whiz, enjoyed soccer, and played the violin in the county youth orchestra. He also was an artist and origamist

 

   On March 20, 2013, Joey was diagnosed with a stage 4 translocation renal cell carcinoma (tRCC). We were told there was no standard treatment for this cancer. Joey underwent two major surgeries, four different oral chemotherapies and one round of radiation. His tumors grew more and spread.

 

   In April 2014, we started a petition of compassionate use of a new immunotherapy drug called Opdivo (nivolumab) that targets the type of tumors that Joey had. It was already in trials and saving the lives of adult cancer patients, but there were no trials available for children. The petition was not granted

 

   On September 4th, another immunotherapy drug Keytruda (pembrolizumab) was approved by the FDA with adult melanoma patients.  Joey started the off-label use of Keytruda. He showed no major side effects from this drug and his tumors in his neck shrank significantly and all other tumors were stable.

 

We had so much hope. However, his tiny body was too exhausted to fight so much disease. On November 24, 2014, Joey slipped into a coma.

Joey passed away two days later.

   Joey’s journey led to the founding of a 100% volunteer-led pediatric cancer research charity, Joey’s Wings Foundation [see below for link]. Joey’s Wings has worked with the nation’s top researchers in renal cell carcinoma to discover a cure for kidney cancer and develop transforming patient care.

Joey’s Wings provides:

~free tutoring services for children battling cancer,

~offers a patient registry and tissue bank for families to connect,

~lobbies for legislation to improve treatment options, and

~provides financial assistance for pediatric kidney cancer patients.

   Joey’s love of origami inspired us to establish the Cranes for a Cure campaign, one of the foundation’s many fundraisers for pediatric cancer research and awareness. We sell colorful origami strings and mobiles consisting of paper cranes, provide them to cancer patients, and create large public art installations using the folded cranes.  By making large string mobiles, each with 2,000 cranes, these art installations would create an impactful vision and raise awareness that 2,000 children die each year from cancer.

   Joey’s Wings is incredibly grateful for all the support from the community which makes it possible for our researchers to develop less toxic therapies to treat kidney cancer among children and young adults.



Joey's Wings

Joey’s Wings Foundation, a 501c3 non-profit charity, was established in 2014 in the memory of Joey Xu, who was taken from us by childhood cancer on Nov. 26, 2014. Joey was diagnosed with xp11.2 translocation renal cell carcinoma, a rare but aggressive cancer, which has no standard treatment protocol. Our mission is to fund research that focuses on kidney cancers affecting children and young adults, raise awareness and provide support to families affected by childhood cancer.

Ten year old Joey Xu was a 5th grader at Talbot Elementary School in Gainesville, Florida. Friends and teachers described him as a funny, kind, caring, gentle, and loving boy. Joey was an intellectually gifted student. He was the award winner of the Florida Math League contest. He loved all things science and was an avid reader. Joey played the violin in the Alachua County Youth Orchestra. He was also an artist and an origamist. He loved Lego, Minecraft and soccer. Joey’s big dream was to one day play the violin in the Carnegie Hall of New York.

 

—————————
   Elevate extends heartfelt gratitude to Joey’s family for graciously sharing their talented and beloved son, Joey, even in the face of his kidney cancer diagnosis, translocation renal cell carcinoma and passing. 

 

   Joey’s experience is why Elevate is reimagining treatments for childhood cancer. Our children need us all. His experience is not isolated, but bears a painful example that so many families have now experienced.

In 2014…another immunotherapy drug Keytruda (pembrolizumab) was approved by the FDA with adult melanoma patients.  Joey started the off-label use of Keytruda. He showed no major side effects from this drug and his tumors in his neck shrank significantly and all other tumors were stable.”

It would be 2020 before Keytruda was approved by the FDA in cases of solid tumors in children with high mutational burden. [LINK Here] This is unacceptable. We must do better.

 

   As an organization Elevate seek’s to dramatically improve the lives of those diagnosed with childhood cancer. When you choose to collaborate alongside us you provide the opportunity to ‘let kids be kids‘ and change lives.

ELEVATE at the FDA

  "      "Making more drugs available to kids with cancer means solving a million small problems. Yesterday’s event provided a necessary opportunity to bring more and more of those problems to light. If we can identify the problems, name the problems, then we can...

Tatum and Maisie Moving Mountains

"The challenges of being a pediatric cancer family are innumerable. Every time you think you’ve found the worst thing, something else rears its ugly head. These past few weeks we’ve witnessed a hefty serving of that humanity, led by two young girls, Tatum Pillor and...

Outwork the Noise

Don’t listen to those voices. Let your hard work, sweat and exertion drown out the noise.  Outwork the noise. -Justin Spoon Outwork the noise means something different for each of us. Robyn Spoon, Elevate Founder shares what this meant to Justin, and what it means to...

A Son, Brother, Collegiate Runner and Asbury Graduate Diagnosed with Rhabdomyosarcoma

"Today, you don't have to do something special. You don't have to do anything amazing or overwhelming. You just gotta get of bed and do something."    - Justin Spoon - A mother's share:     Sitting in a small Lexington, Kentucky clinic room with my then 21-year-old...

Ewings Sarcoma Mom Shares

"Her diagnosis story is probably best classified as ‘trust your gut and ask for the extra tests’."    - Aimee Formo, Ewings Sarcoma Survivor's mom & Childhood Cancer AdvocateGuest Blog by: Aimee Formo    Ewings sarcoma, also abbreviated EWS,  is an aggressive type...

Rhabdomyosarcoma: A Bereaved Mom Shares

Guest Blog by: Cindy Cleveland   Matt Cleveland 2/5/1997-3/8/2023  "From the time Matthew was little, he could most frequently be found playing baseball," Matthew's mom Cindy shares with Elevate.   "His love for the game started with T-Ball at the age of 4, continued...

First Look: Parents Share How They First Discovered Their Child Had Rhabdomyosarcoma

"A small, relatively painless lump near his left nostril had a name- Rhabdomyosarcoma"    - Robyn Spoon, Elevate CEO & Founder    "Rhabdomyosarcoma is rare, with only about 500 total diagnoses in the US each year and only a small percentage of those above the age...

Multi-Stakeholder Engagement for Wilms Tumor that Puts Children in the Center

“Organizing ideas for presentation is one of the best ways to learn. What we learn we can teach. I learned a new concept through working on the poster—design thinking. And learning about this subject was the beginning of teaching it in our role as advocates, a...

Elevate Wilms at the 12th International Pediatric Renal Tumors Biology Meeting

"Five years ago I was sitting across from the oncologists, today, I sit with them."    - C. Comer MTS, BSN, RN,Mike Ortiz, MD and Robyn Spoon, Elevate CEO       Great things that happened in New York to make a difference for Wilms tumor. Elevate Wilms...

Change Starts From the Ground Up

"Elevate provides a space to work towards solutions and a platform to make effective change."    - C. Comer MTS, BSN, RN,Guest Blog by: C. Comer MTS, BSN, RN       In the past, people with a common cause may have had coffee. Today, they zoom or form social media...

@2023 ELEVATE Childhood Cancer Research
and Advocacy, Inc.
is a registered 501(c)(3) non-profit organization.
EIN: 93-2185372

Join us! Stay up to date with our work and mission.

12 + 4 =

Please help keep our site secure and solve this problem.

We respect your privacy and will never sell or share your information.